… that anti-RBD antibody levels, neutralization titer, and neutralization potency associated with
disease severity and predicted survival, but largely lacked cross-neutralizing activity to pre-…

… disease severity in patients recovered from COVID-19. We have also found that disease
severity also influences the neutralization heterogeneity of SARS-CoV2-specific antibodies. Our …

… titers as measured by Plaque reduction neutralization titers (PRNT 50 ) decline are also
dependent on the severity of symptoms. Severe ill patients retain antibodies longer than mild …

… For our initial analysis, hospitalized patients were first stratified based on disease severity
into moderate and severe disease groups by levels of supplemental oxygen requirement and …

… of neutralizing antibody levels at different time since onset from different severity COVID-19
inpatients … Third, the subjects were mainly mild or moderate by illness severity, and only 1 …

… are detected in a significant proportion of severe COVID-19. NAB positive patients presented
a defective IFN response and increased levels of laboratory biomarkers of disease severity. …

… great significance for the long-term control and treatment of COVID-19. … neutralizing antibody
levels at different times since onset from COVID-19 patients with different disease severity …

… of disease severity from mild upper respiratory symptoms to respiratory failure. The role of
neutralizing antibody (NAb) response in disease … of 733 non-COVID-19 individuals from April …

… antibody response in a cohort of 94 COVID-19 convalescent patients. To efficiently assess
neutralization… pseudotype-based neutralization assay. We evaluated the relationship between …

… well described for severe COVID-19. Here we analyse whether neutralising antibody titre
remains … It will be increasingly important to understand disease severity as an endpoint in future …